SPIRIFY PHARMA INC
Biotech · Private
2R6R-hydroxynorketamine (2R6R-HNK), a ketamine metabolite therapeutic for chronic pain
- Grants
- $291K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 3 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · HNK analog identification and characterization as an approach to non-opioid analgesics | $290,784 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2432 | GLSYNTHESIS, INC. | — | — |
| 2433 | PRAXIS BIORESEARCH, LLC | — | — |
| 2434 | Coactigon, Inc. | — | — |
| 2435 | SPIRIFY PHARMA INC | — | — |
| 2436 | ENDURX PHARMACEUTICALS, INC. | — | — |
| 2437 | Palvella Therapeutics, Inc. | — | $63M |
| 2438 | Tracon Pharmaceuticals, Inc. | — | $57M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Hydroxynorketamine Analogues, Compositions Comprising Same And Methods Of Use Thereofgranted
- Phenyl Cyclohexanone Derivatives And Methods Of Making And Using Themapplication
- Phenyl Cyclohexanone Derivatives And Methods Of Making And Using Themgranted
- Compositions And Methods For The Treatment And Management Of Inflammation Using Hydroxynorketamineapplication
- Phenyl Cyclohexanone Derivatives And Methods Of Making And Using Themgranted
- Hydroxynorketamine Analogs And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.